Navigation Links
The National Coalition for Cancer Survivorship Joins the Commission on Cancer
Date:2/9/2010

WASHINGTON, Feb. 9 /PRNewswire-USNewswire/ -- The National Coalition for Cancer Survivorship (NCCS) has accepted an invitation to join the Commission on Cancer (CoC), a multidisciplinary organization administered by the American College of Surgeons dedicated to reducing the morbidity and mortality of cancer through education, standards setting, and the monitoring of quality of care.

The CoC has invited NCCS, a key patient advocacy organization, to join with its members' efforts to improve the quality of care and services received by cancer patients.

"We are very pleased that NCCS has been invited to join the Commission on Cancer," said Thomas P. Sellers, President & CEO of NCCS. "We believe the evolution of the Commission on Cancer's mission aligns well with our mission to ensure that all Americans have access to high quality cancer care that is comprehensive, coordinated, and patient-centered. We look forward to advancing this important work together."

By joining the Commission, NCCS has the opportunity to ensure patients' voices are heard as CoC accredits cancer programs at over 1,400 hospitals and health care organizations nationwide and collects information for over 70 percent of all cancer patients treated in the United States.

NCCS will collaborate with the CoC on efforts including using the Commission's National Cancer Data Base and hospital registries to produce patient care summaries and care plans. NCCS has long advocated for the widespread use of cancer treatment plans and summaries and post-treatment care plans as an essential part of quality cancer care.

Through its public policy and grassroots outreach, NCCS educates cancer survivors and decision makers about the need for cancer care planning, which coordinates care among multiple specialists and settings, eliminates duplicative testing, and eases patients' anxiety about the difficult transitions before, during and after cancer treatment. NCCS also collaborates in programs such as Journey Forward (www.JourneyForward.org), which provides free tools that help doctors and patients work together to create a treatment summary and post-treatment care plan.  

The National Coalition for Cancer Survivorship (NCCS) advocates for quality cancer care for all Americans and provides tools that empower people affected by cancer to advocate for themselves.  Founded by and for cancer survivors in 1986, NCCS created the widely accepted definition of survivorship and considers someone a cancer survivor from the time of diagnosis through the balance of life. 

SOURCE National Coalition for Cancer Survivorship

RELATED LINKS
http://www.canceradvocacy.org/

'/>"/>

SOURCE National Coalition for Cancer Survivorship
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. NationalCreditReport.com Reminds Consumers of Ways to Improve Credit Report and Score in 2010
2. National Patient Safety Foundation Leads Nationwide Effort to Promote Patient Safety
3. Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results
4. Qui Tam Attorney Tim Terry Participating in Training Event Sponsored by Puget Sound Chapter of the National Contract Management Association (NCMA)
5. SnapSports Releases ReActive Court Surfacing For The International Sports Market
6. Reliv International Expands Its Relivables Line
7. HSS Supports Arthritis Foundation Focus on Raising National Awareness of Osteoarthritis
8. National Health Investors Sets Fourth Quarter Earnings Release and Conference Call Dates
9. Memory Loss Supplement Manufacturer Partners With Nationally-Syndicated Radio Host John Tesh
10. Royal Caribbean International and LimoRes.com Announce Exclusive Partnership
11. Global Aids Alliance Celebrates the Introduction of the International Violence Against Women Act, Urges Swift Passage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: